-
公开(公告)号:US20180327486A1
公开(公告)日:2018-11-15
申请号:US15973225
申请日:2018-05-07
Applicant: NOVARTIS AG
Inventor: Leslie Ngozi Anuna JOHNSON , Ute JAEGER , Yong-In KIM , Christian Carsten Silvester KUNZ , Igor SPLAWSKI , Michael ROGUSKA , Joy GHOSH , Barbara BRANNETTI , Michael STEFANIDAKIS , Sha-Mei LIAO
IPC: C07K16/18 , C07K16/24 , G01N33/68 , A61K39/395
CPC classification number: C07K16/18 , A61K39/3955 , A61K2039/505 , A61K2039/507 , C07K16/24 , C07K2317/21 , C07K2317/30 , C07K2317/33 , C07K2317/40 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92 , G01N33/6863
Abstract: The present invention relates to antibodies or antigen binding fragments thereof that bind to complement Factor P and used thereof as well as combinations of anti-Factor P antibodies with antibodies or antigen binding fragments thereof that bind to complement component 5 (C5).